Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jan 31;13(1):e0190529.
doi: 10.1371/journal.pone.0190529. eCollection 2018.

Low prevalence of HCV infection with predominance of genotype 4 among HIV patients living in Libreville, Gabon

Affiliations

Low prevalence of HCV infection with predominance of genotype 4 among HIV patients living in Libreville, Gabon

Angélique Ndjoyi-Mbiguino et al. PLoS One. .

Abstract

Background: Gabon is an endemic area for human immunodeficiency virus (HIV) and hepatitis C virus (HCV) and the risk of co-infection is high.

Method: Between November 2015 and April 2016, we conducted retrospective study on HCV infection among people living with HIV/AIDS (PLHA). A total of 491 PLHA were included in this study and tested for the presence of HCV infection. HIV viral loads were obtained using the Generic HIV viral Load® assay and the CD4+ T cells count was performed using BD FACSCount™ CD4 reagents. HCV screening was performed using the MP Diagnostics HCV ELISA 4.0 kit. HCV genotypes were determined by sequence analysis of NS5B and Core regions. The Mann-Whitney test was used to compare the groups. Chi-2 test and Fisher's Exact Test were used to compare prevalence.

Results: HCV seroprevalence was 2.9% (14/491), (95% confidence interval (CI):1.4-4.3%). The percentage of HCV viremic patients, defined by the detection of HCV RNA in plasma, was 57% (8/14), representing 1.6% of the total population. HCV seroprevalence and replicative infection were not statistically differ with gender. The percentage of co-infection increased with age. No correlation with CD4+ T cells count and HIV viral load level was registered in this study. Identified HCV strains were predominantly of genotype 4 (87.5%) including 4k, 4e, 4g, 4p, 4f and 4c subtypes. Only one strain belonged to genotype 2 (subtype 2q). Analysis of the NS5B region did not reveal the presence of resistance-associated substitutions for sofosbuvir.

Conclusion: A systematic screening of hepatitis C is therefore strongly recommended as well as genotyping of HCV strains in order to adapt treatments for the specific case of people living with HIV/AIDS in Central Africa.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Phylogenetic analysis of HCV NS5B sequences.
Neighbor-joining phylogenetic tree constructed with our sequences and reference sequences for HCV genotypes retrieved from the GenBank. The Kimura two-parameter method of estimating genetic distance was used. Numbers next to the nodes of the tree represent bootstrap values (1000 replicates). Branches for genotype 4 are indicated in red and in green for genotype 2. Our sequences are preceded by a spot. The Gen-Bank accession numbers of the new NS5b sequences of HCV are KY661744 to KY661751.
Fig 2
Fig 2. Phylogenetic analysis of HCV Core sequences.
Neighbor-joining phylogenetic tree constructed with our sequences and reference sequences for HCV genotypes retrieved from the Gen-Bank. The Kimura two-parameter method of estimating genetic distance was used. Numbers next to the nodes of the tree represent bootstrap values (1000 replicates). Branches for genotype 4 are indicated in red and in green for genotype 2. Our sequences are preceded by a spot. The Gen-Bank accession numbers of the new core sequences of HCV are KY661736 to KY661743.

Similar articles

References

    1. Pei R, Grund S, Verheyen J, Esser S, Chen X, Lu M (2014) Spontaneous reactivation of hepatitis B virus replication in an HIV coinfected patient with isolated anti-Hepatitis B core antibodies. Virol J 11: 9 doi: 10.1186/1743-422X-11-9 - DOI - PMC - PubMed
    1. Fabbri G, Mastrorosa I, Vergori A, Mazzotta V, Pinnetti C, Grisetti S, et al. (2017) Reactivation of occult HBV infection in an HIV/HCV Co-infected patient successfully treated with sofosbuvir/ledipasvir: a case report and review of the literature. BMC Infect Dis 17: 182 doi: 10.1186/s12879-017-2287-y - DOI - PMC - PubMed
    1. Modi AA, Feld JJ (2007) Viral hepatitis and HIV in Africa. AIDS Rev 9: 25–39. - PubMed
    1. Rao VB, Johari N, du Cros P, Messina J, Ford N, Cooke GS (2015) Hepatitis C seroprevalence and HIV co-infection in sub-Saharan Africa: a systematic review and meta-analysis. Lancet Infect Dis 15: 819–824. doi: 10.1016/S1473-3099(15)00006-7 - DOI - PubMed
    1. WHO (2016) HIV/AIDS Fact Sheet: available online 05–2017 http://wwwwhoint/mediacentre/factsheets/fs360/en/.

Publication types

MeSH terms